Postes actifs de Edwin P. Ching
Sociétés | Poste | Début | Fin |
---|---|---|---|
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Directeur/Membre du Conseil | - | - |
Fondateur | - | - | |
Secrétaire Général | 11/03/2010 | 18/06/2015 |
Historique de carrière de Edwin P. Ching
Anciens postes connus de Edwin P. Ching
Sociétés | Poste | Début | Fin |
---|---|---|---|
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Corporate Officer/Principal | - | - |
GangaGen, Inc.
GangaGen, Inc. BiotechnologyHealth Technology GangaGen, Inc. develops novel therapies for veterinary and agricultural applications. It focuses on the discovery and development of novel therapeutics for the prevention and treatment of infectious diseases, particularly infections that are resistant to antibiotics. The company was founded by Janakiraman Ramachandran on September 23, 2000 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - | - |
Formation de Edwin P. Ching
California Institute of Technology | Doctorate Degree |
Columbia Law School | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Opérationnelle
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Founder | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Emiliem, Inc.
Emiliem, Inc. BiotechnologyHealth Technology Emiliem, Inc. develops drugs for the treatment of cancer. The firm is particularly interested in diagnostic markers for rare diseases and the computational aspects of predicting both positive and negative patient outcomes. The company was founded by James E. Burden and Sucha Sudarsanam in 2005 and is headquartered in Berkeley, CA. | Health Technology |
GangaGen, Inc.
GangaGen, Inc. BiotechnologyHealth Technology GangaGen, Inc. develops novel therapies for veterinary and agricultural applications. It focuses on the discovery and development of novel therapeutics for the prevention and treatment of infectious diseases, particularly infections that are resistant to antibiotics. The company was founded by Janakiraman Ramachandran on September 23, 2000 and is headquartered in Palo Alto, CA. | Health Technology |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Health Technology |
- Bourse
- Insiders
- Edwin P. Ching
- Expérience